By Denny Jacob Johnson & Johnson is scheduled to report its fourth-quarter results Tuesday before the market opens. Here's what you need to know. NET.
Artificial intelligence can improve data integrity, provide stronger predictions in the supply chain, and give finance leaders more time to focus on strategy.
Johnson & Johnson (NYSE:JNJ) on Tuesday forecast revenue growth of 5% to 6% for the next year, as it banks on strong demand for cancer treatments Darzalex and Carvykti and resilient sales of blockbuster drug Stelara.
The company has narrowed its .